Statistics
Publications
4
Citations
255
H-Index
4
Active since
2020
Gary Rafaloff is an author at Van Andel Institute specializing in parkinson’s disease pharmacotherapy, medicine, and clinical neuroscience.
Publications per year
2020–2023
4
4
Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease
Tanya Simuni, Brian Fiske, Kalpana Merchant et al. · JAMA Neurology · 2020 · 143 citations · Full text
Medicine, Neurology, Pharmacology +17
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
Kevin McFarthing, Susan Buff, Gary Rafaloff et al. · Journal of Parkinson s Disease · 2023 · 89 citations · Full text
Medicine, Neurology, Neuroscience +16
Nilotinib in Patients with Advanced Parkinson’s Disease: A Randomized Phase 2A Study (NILO-PD)
Tanya Simuni, Brian Fiske, Kalpana Merchant et al. · medRxiv · 2020 · 12 citations · Full text
Medicine, Neurology, Pharmacology +17
Sally Okun, Morgan Hanger, Letitia Browne-James et al. · Journal of Medical Internet Research · 2023 · 11 citations · Full text
1–4 of 4